Good Catch! How to Identify and Manage Common Antiretroviral Drug Interactions

Presenter: Katherine Lepik
Location: Conference Room 6, Providence Building Level 1, St. Paul’s Hospital
Date: Wednesday, February 27, 2019
Kathy Lepik is the Research Coordinator of the BC Centre for Excellence in HIV/AIDS Pharmacovigilance Initiative, where she is responsible for tracking, analyzing, and following up on adverse reactions and drug interactions to antiretroviral drugs. Her work also involves initiating measures to improve patient safety and managing research projects. Kathy is also a clinical pharmacist providing patient care through the St Paul’s Hospital Ambulatory Pharmacy.
Credit: This 1-credit-per-hour Group Learning program has been certified by the College of Family Physicians of Canada and the BC Chapter for up to 1 Mainpro+ credits.
Registration: Eventbrite - Forefront Lectures


Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025